IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

Authors

Jennifer Sun, Washington University School of Medicine in St. Louis
Monica Shokeen, Washington University School of Medicine in St. Louis
Barbara Muz, Washington University School of Medicine in St. Louis
Kinan Alhallak, Washington University School of Medicine in St. Louis
Chaelee Park, Washington University School of Medicine in St. Louis
Berit Lubben, Washington University School of Medicine in St. Louis
Yixuan Chen, Washington University School of Medicine in St. Louis
Ola Adebayo, Washington University School of Medicine in St. Louis
Hannah Bash, Washington University School of Medicine in St. Louis
Sarah Kelley, Washington University School of Medicine in St. Louis
Mark Fiala, Washington University School of Medicine in St. Louis
Diane E Bender, Washington University School of Medicine in St. Louis
Ravi Vij, Washington University School of Medicine in St. Louis
Abdel Kareem Azab, Washington University School of Medicine in St. Louis
et al.

Journal

Leukemia

Publication Date

11-1-2024

Volume

38

Issue

11

First Page

2355

Last Page

2365

Document Type

Open Access Publication

DOI

10.1038/s41375-024-02391-8

Rights and Permissions

Sun, J., Corradini, S., Azab, F. et al. IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia 38, 2355–2365 (2024). https://doi.org/10.1038/s41375-024-02391-8 This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Recommended Citation

Sun, Jennifer; Shokeen, Monica; Muz, Barbara; Alhallak, Kinan; Park, Chaelee; Lubben, Berit; Chen, Yixuan; Adebayo, Ola; Bash, Hannah; Kelley, Sarah; Fiala, Mark; Bender, Diane E; Vij, Ravi; Azab, Abdel Kareem; and et al., "IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma." Leukemia. 38, 11. 2355 - 2365. (2024).
https://digitalcommons.wustl.edu/oa_4/4512

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.